According to the latest report published by Credence Research, Inc. “Ophthalmic Drugs Market – (Prescription Type – Prescription Ophthalmic Drugs and Over the Counter (OTC) Drugs; Therapeutic Type: Glaucoma Ophthalmic Drugs, Retinal Disorder Ophthalmic Drugs, Dry Eye Ophthalmic Drugs and Allergic Conjunctivitis): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the market was valued at USD 17.2 Bn in 2015, and is expected to reach USD 27.6 Bn by 2022, expanding at a CAGR of 7.0% from 2016 to 2022.
Browse the full report Ophthalmic Drugs Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/ophthalmic-drugs-market
Globally, average life expectancy has been increasing and it’s posturing medical issues within the ophthalmology field. Among the elderly population, vision loss is a major healthcare problem. The growing prevalence of eye–related disorders has created huge scope for ophthalmic drugs. Moreover, new technologies combining drugs and device therapies are contributing significantly towards the development of ophthalmic drugs market.
North America accounted for the largest market in the ophthalmic drugs market due to the rising number of patient population suffering from ocular diseases in the region. The prevalence of blindness and vision impairment and other eye related disorders is expected to increase rapidly among all age group, gender and racial group in North America. Asia Pacific ophthalmic drug market holds high growth potential in near future due to factors such as rising geriatric population, rising investments in healthcare infrastructure and increasing prevalence of ocular diseases.
The ophthalmic drug industry can be classified into prescription ophthalmic drugs and over the counter (OTC) drugs. OTC drugs held the largest market share in the global ophthalmic drugs market. However, prescription ophthalmic drugs segment is anticipated to grow at highest CAGR during the forecast period due to the increasing rate of success for newly launched drugs which can only be bought by prescriptions assisting the market growth.
Browse the full report at http://www.credenceresearch.com/report/ophthalmic-drugs-market
Among the therapeutic areas, glaucoma ophthalmic drugs held the largest share in global ophthalmic drugs market. It is estimated that over three million Americans are suffering from glaucoma, being the leading cause of blindness in people of 60 years of age. However, the retinal disorder ophthalmic drug is anticipated to grow at highest CAGR due higher prevalence rate among people in the world. Thus the treatment for retinal disorders has the highest growth.
Medical Waste Management Market By Waste Type (Collective Waste, Infectious Waste, Pathological Waste, Sharps, Pharmaceutical Waste, Genotoxic Waste, Chemical Waste), By Techniques (Incineration Process, Non-Incineration Processes), By Activity (Treatment, Disposal, Recycling) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith
Designation: Global Sales Manager
Web: Credence Research
Release ID: 5578